Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
Subscribe To Our Newsletter & Stay Updated